Omnicell, Inc. (OMCL) Chairman Sells $605,804.98 in Stock

Share on StockTwits

Omnicell, Inc. (NASDAQ:OMCL) Chairman Randall A. Lipps sold 9,482 shares of the firm’s stock in a transaction on Tuesday, December 18th. The stock was sold at an average price of $63.89, for a total value of $605,804.98. Following the completion of the transaction, the chairman now owns 165,025 shares of the company’s stock, valued at approximately $10,543,447.25. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink.

NASDAQ OMCL opened at $63.75 on Wednesday. The stock has a market cap of $2.52 billion, a price-to-earnings ratio of 354.17, a P/E/G ratio of 3.80 and a beta of 0.99. Omnicell, Inc. has a fifty-two week low of $39.75 and a fifty-two week high of $79.48. The company has a quick ratio of 1.32, a current ratio of 1.78 and a debt-to-equity ratio of 0.27.

Omnicell (NASDAQ:OMCL) last released its quarterly earnings data on Thursday, October 25th. The company reported $0.49 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.40 by $0.09. The business had revenue of $204.27 million during the quarter, compared to analyst estimates of $203.48 million. Omnicell had a return on equity of 7.91% and a net margin of 6.11%. Analysts forecast that Omnicell, Inc. will post 1.42 EPS for the current year.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. American International Group Inc. raised its stake in shares of Omnicell by 2.9% during the 3rd quarter. American International Group Inc. now owns 30,486 shares of the company’s stock valued at $2,192,000 after buying an additional 873 shares during the last quarter. First National Bank of Omaha raised its stake in shares of Omnicell by 2.9% during the 3rd quarter. First National Bank of Omaha now owns 33,102 shares of the company’s stock valued at $2,380,000 after buying an additional 925 shares during the last quarter. Bahl & Gaynor Inc. raised its stake in shares of Omnicell by 2.4% during the 3rd quarter. Bahl & Gaynor Inc. now owns 44,608 shares of the company’s stock valued at $3,207,000 after buying an additional 1,045 shares during the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS raised its stake in shares of Omnicell by 14.0% during the 3rd quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 9,375 shares of the company’s stock valued at $674,000 after buying an additional 1,151 shares during the last quarter. Finally, Paloma Partners Management Co raised its stake in shares of Omnicell by 25.6% during the 2nd quarter. Paloma Partners Management Co now owns 5,989 shares of the company’s stock valued at $314,000 after buying an additional 1,222 shares during the last quarter. Institutional investors and hedge funds own 98.80% of the company’s stock.

A number of equities analysts recently issued reports on OMCL shares. Craig Hallum raised their target price on Omnicell from $65.00 to $80.00 and gave the stock a “buy” rating in a research note on Monday, September 17th. Cantor Fitzgerald raised their target price on Omnicell from $63.00 to $70.00 and gave the stock an “overweight” rating in a research note on Friday, October 26th. raised their target price on Omnicell from $59.00 to $71.00 and gave the stock an “in-line” rating in a research note on Monday, October 22nd. Benchmark raised their target price on Omnicell from $66.00 to $79.00 and gave the stock a “buy” rating in a research note on Friday, October 5th. Finally, BidaskClub lowered Omnicell from a “strong-buy” rating to a “buy” rating in a research note on Thursday, October 4th. Three equities research analysts have rated the stock with a hold rating, six have issued a buy rating and one has issued a strong buy rating to the stock. The company presently has a consensus rating of “Buy” and an average price target of $73.75.

TRADEMARK VIOLATION NOTICE: “Omnicell, Inc. (OMCL) Chairman Sells $605,804.98 in Stock” was originally reported by Week Herald and is the property of of Week Herald. If you are accessing this news story on another domain, it was copied illegally and republished in violation of United States & international copyright legislation. The original version of this news story can be viewed at https://weekherald.com/2018/12/19/omnicell-inc-omcl-chairman-sells-605804-98-in-stock.html.

Omnicell Company Profile

Omnicell, Inc provides automation and business analytics software solutions for medication and supply management in healthcare worldwide. The company operates through two segments, Automation and Analytics, and Medication Adherence. It offers Omnicell Automated Dispensing Cabinets, a dispensing system, which automates the management and dispensing of medications; SinglePointe, a software product that controls medications; AnywhereRN, a software which remotely queue medications from automated dispensing cabinets; Omnicell Analytics and Pandora Analytics reporting and data analytics tools; and Anesthesia Workstation that manages anesthesia supplies and medications.

Featured Article: Call Option

Insider Buying and Selling by Quarter for Omnicell (NASDAQ:OMCL)

Receive News & Ratings for Omnicell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omnicell and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply